Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference

Robert C. Bast, Ursula A. Matulonis, Anil K. Sood, Ahmed A. Ahmed, Adaobi E. Amobi, Frances R. Balkwill, Monicka Wielgos-Bonvallet, David D. L. Bowtell, James D. Brenton, Joan S. Brugge, Robert L. Coleman, Giulio F. Draetta, Kai Doberstein, Ronny I. Drapkin, Mark A. Eckert, Robert P. Edwards, Kevin M. Elias, Darren Ennis, Andrew Futreal, David M. GershensonRoger A. Greenberg, David G. Huntsman, Jennifer Xiao Ye Ji, Elise C. Kohn, Claudia Iavarone, Ernst R. Lengyel, Douglas A. Levine, Christopher J. Lord, Zhen Lu, Gordon B. Mills, Francesmary Modugno, Brad H. Nelson, Kunle Odunsi, Jessica A. Pilsworth, Robert K. Rottapel, Daniel J. Powell, Li Shen, Ie-Ming Shih, David R. Spriggs, Josephine Walton, Kaiyang Zhang, Rugang Zhang, Lee Zou

Research output: Contribution to journalEditorialScientific

Original languageEnglish
JournalCancer
Volume125
Issue number12
Pages (from-to)1963-1972
Number of pages10
ISSN0008-543X
DOIs
Publication statusPublished - 15 Jun 2019
MoE publication typeB1 Journal article

Fields of Science

  • drug resistance
  • early detection
  • heterogeneity
  • immunotherapy
  • metabolism
  • microenvironment
  • ovarian cancer
  • PARP inhibitors
  • prevention
  • UK COLLABORATIVE TRIAL
  • GRADE SEROUS CARCINOMA
  • INDUCIBLE KINASE 2
  • MAINTENANCE THERAPY
  • HOMOLOGOUS RECOMBINATION
  • OPEN-LABEL
  • TUMOR
  • WOMEN
  • OLAPARIB
  • PERITONEUM
  • 3122 Cancers

Cite this